236 related articles for article (PubMed ID: 11981471)
1. [Factors related to screening of hepatitis C virus in general medicine].
Rotily M; Loubière S; Prudhomme J; Portal I; Tran A; Hofliger P; Valla D; Moatti JP
Gastroenterol Clin Biol; 2002 Mar; 26(3):261-9. PubMed ID: 11981471
[TBL] [Abstract][Full Text] [Related]
2. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
[TBL] [Abstract][Full Text] [Related]
3. [General practice patterns in hepatitis C virus mass screening in the Lyons region].
Sahajian F; Caillat-Vallet E; Bailly F; Excler G; Trepo C; Fabry J; Sepetjan M
Sante Publique; 1999 Dec; 11(4):513-25. PubMed ID: 10798177
[TBL] [Abstract][Full Text] [Related]
4. [Screening and hepatitis C management survey in general medicine in the Alpes-Maritimes and east Var area].
Ouzan D; Hofliger P; Cavailler P; Mamino C; Tran A
Gastroenterol Clin Biol; 2003 Jan; 27(1):90-3. PubMed ID: 12594371
[TBL] [Abstract][Full Text] [Related]
5. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
6. Dental screening and referral of young children by pediatric primary care providers.
dela Cruz GG; Rozier RG; Slade G
Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
[TBL] [Abstract][Full Text] [Related]
7. [Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region].
Bonny C; Rayssiguier R; Ughetto S; Aublet-Cuvelier B; Baranger J; Blanchet G; Delteil J; Hautefeuille P; Lapalus F; Montanier P; Bommelaer G; Abergel A
Gastroenterol Clin Biol; 2003 Nov; 27(11):1021-5. PubMed ID: 14732848
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program.
Lapane KL; Jakiche AF; Sugano D; Weng CS; Carey WD
Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
11. [Screening of patients at risk for hepatitis C virus infection in general medicine].
Altman C; Lesiour A; Dunbavand A; Meyer L; de la Selle P; Buffet C
Gastroenterol Clin Biol; 1999 Mar; 23(3):359-62. PubMed ID: 10384340
[TBL] [Abstract][Full Text] [Related]
12. [Do general practitioners want to manage chronic hepatitis C and take part in hepatitis C health networks? A national survey].
Babany G; Bourlière M; Chevalier H; Chousterman M; Couzigou P; Desmorat H; Dhumeaux D; Doffoël M; Gournay J; Loiseau D; Mercet P; Moussalli J; Trépo C; Tucat G; Doan Tran D; Saint-Marc-Girardin MF
Gastroenterol Clin Biol; 1999 Dec; 23(12):1289-95. PubMed ID: 10642617
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
14. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C].
Niederau C; Bemba G; Kautz A
Z Gastroenterol; 2006 Apr; 44(4):305-17. PubMed ID: 16625459
[TBL] [Abstract][Full Text] [Related]
15. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
16. [Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district].
Ouzan D; Cavailler P; Hofliger P; Mamino C; Joly H; Tran A
Gastroenterol Clin Biol; 2003 Apr; 27(4):376-80. PubMed ID: 12759676
[TBL] [Abstract][Full Text] [Related]
17. Access to electronic hepatitis C medical files by general practitioners.
Fages M; Fabbro-Peray P; Daures JP; Ribard D; Mourrut C
Gastroenterol Clin Biol; 2008 Mar; 32(3):224-31. PubMed ID: 18400435
[TBL] [Abstract][Full Text] [Related]
18. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C infection among drug users in northern Thailand.
Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
[TBL] [Abstract][Full Text] [Related]
20. Outcome of screening for hepatitis C virus infection based on risk factors.
Mallette C; Flynn MA; Promrat K
Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
